XLO - Xilio Therapeutics Inc
IEX Last Trade
1.1
0.050 4.545%
Share volume: 230,539
Last Updated: Fri 10 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.88%
PREVIOUS CLOSE
CHG
CHG%
$1.05
-0.02
-0.02%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-14 | 2024-08-08 | 2024-11-07 | |
| Cash flow financing | 954.000 K | 20.043 M | -3.000 K | |
| Other financing cash flows | -21.000 K | -20.000 K | -3.000 K | |
| Cash flow | -9.548 M | 39.975 M | -13.684 M | |
| Net income | -17.203 M | -13.925 M | -14.020 M | |
| Depreciation | 443.000 K | 445.000 K | 381.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | -21.000 K | -9.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 21.000 K | 9.000 K | |
| Cash Change | -9.548 M | 39.975 M | -13.684 M |